Société canadienne de la sclérose latérale amyotrophique

 
 
 
300 - 265 Yorkland Blvd.
Toronto, Ontario
Canada
M2J 1S5
Sigle : SLA Canada
Adresse Internet : http://www.als.ca/

  Projet(s) actif(s)
    Discovery of Therapeutic Targets for FUS-Dependant Forms of ALS.
    Enhancing the efficacy of heat shock protein inducers by cotreatment with a histone deacetylase inhibitor - A therapeutic strategy for ALS
    Targeting SRSF3 to reprogram immune response in ALS
www.ulaval.ca